`
`Paper No. _____
`Date Filed: March 8, 2016
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`________________
`
`MYLAN LABORATORIES LIMITED
`Petitioner,
`v.
`AVENTIS PHARMA S.A.
`Patent Owner.
`________________
`
`Case IPR2016-00627
`U.S. Patent No. 5,847,170
`________________
`
`
`
`PATENT OWNER POWER OF ATTORNEY IN AN INTER PARTES
`REVIEW PURSUANT TO 37 C.F.R. § 42.10(b)
`
`
`
`
`
`
`
`
`
`POWER OF ATTORNEY IN AN INTER PARTES REVIEW
`
`Patent Owner, Aventis Pharma S.A., hereby appoints Practitioners
`
`associated with Customer Number 05514, as attorneys to transact all business in
`
`the United States Patent and Trademark Office connected with the above-identified
`
`matter, including the appointment of lead and backup counsel. Please recognize
`
`the correspondence address (including electronic email address) for the Inter
`
`Partes Review to be the address associated with the appointed lead and backup
`
`counsel. The undersigned has the authority to execute this document on behalf of
`
`Aventis Pharma S.A.
`
`Date: March7 2016
`
`
`
`if ,/,7_ \.,
`/
`/.’I/
`
`Kt
`
`,
`
`Name: Charlotte L. Barn/ell. f
`
`
`Title: Associate Vice President
`
`Aventis Pharma S.A.
`
`FCHS_WS 122975 17vl .doc